alendronate has been researched along with Spinal Diseases in 7 studies
alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.
Spinal Diseases: Diseases involving the SPINE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Alendronate, vitamin D, and calcium are safe and potentially useful in the treatment of osteopenia/osteoporosis associated with HIV infection." | 9.11 | Alendronate, vitamin D, and calcium for the treatment of osteopenia/osteoporosis associated with HIV infection. ( Claxton, SA; Hoffmann, ME; Mondy, K; Powderly, WG; Royal, M; Stoneman, JS; Tebas, P; Yarasheski, KH, 2005) |
| "Alendronate, vitamin D, and calcium are safe and potentially useful in the treatment of osteopenia/osteoporosis associated with HIV infection." | 5.11 | Alendronate, vitamin D, and calcium for the treatment of osteopenia/osteoporosis associated with HIV infection. ( Claxton, SA; Hoffmann, ME; Mondy, K; Powderly, WG; Royal, M; Stoneman, JS; Tebas, P; Yarasheski, KH, 2005) |
| "There are very few cases of pathological fracture induced by pancreatitis that affect the vertebrae." | 1.37 | Pathological fracture due to vertebral osteonecrosis associated with pancreatitis. ( Baba, T; Kaneko, H; Shitoto, K; Yoshioka, C, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kallmes, DF | 1 |
| Rad, AE | 1 |
| Gray, LA | 1 |
| McDonald, RJ | 1 |
| Clarke, BL | 1 |
| Baba, T | 1 |
| Shitoto, K | 1 |
| Yoshioka, C | 1 |
| Kaneko, H | 1 |
| Zhang, LL | 1 |
| Zhao, JX | 1 |
| Liu, XY | 1 |
| Minne, HW | 1 |
| Pöllhane, W | 1 |
| Karpf, DB | 1 |
| Chun, CS | 1 |
| Mondy, K | 1 |
| Powderly, WG | 1 |
| Claxton, SA | 1 |
| Yarasheski, KH | 1 |
| Royal, M | 1 |
| Stoneman, JS | 1 |
| Hoffmann, ME | 1 |
| Tebas, P | 1 |
| Sahota, O | 1 |
| Fowler, I | 1 |
| Blackwell, PJ | 1 |
| Lawson, N | 1 |
| Cawte, SA | 1 |
| San, P | 1 |
| Masud, T | 1 |
| Hosking, DJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Prevalence of Vitamin D Deficiency and Effects of Vitamin D Supplementation in HIV-1 Infected Patients[NCT00306410] | Phase 2 | 85 participants | Interventional | 2006-01-31 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for alendronate and Spinal Diseases
| Article | Year |
|---|---|
Chronic recurrent multifocal osteomyelitis of the spine and mandible: case report and review of the literature.
Topics: Alendronate; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Child, Preschool; Chron | 2004 |
3 trials available for alendronate and Spinal Diseases
| Article | Year |
|---|---|
The effects of alendronate on stature and the spine deformity index.
Topics: Administration, Oral; Alendronate; Analysis of Variance; Body Height; Double-Blind Method; Female; H | 1999 |
Alendronate, vitamin D, and calcium for the treatment of osteopenia/osteoporosis associated with HIV infection.
Topics: Absorptiometry, Photon; Adult; Alendronate; Bone Density; Bone Diseases, Metabolic; Calcium; CD4 Lym | 2005 |
A comparison of continuous alendronate, cyclical alendronate and cyclical etidronate with calcitriol in the treatment of postmenopausal vertebral osteoporosis: a randomized controlled trial.
Topics: Administration, Oral; Aged; Aged, 80 and over; Alendronate; Biomarkers; Bone Density; Bone Remodelin | 2000 |
3 other studies available for alendronate and Spinal Diseases
| Article | Year |
|---|---|
Bisphosphonates are not associated with vertebral osteonecrosis.
Topics: Adult; Aged; Aged, 80 and over; Alendronate; Bone Density; Diphosphonates; Female; Humans; Male; Mid | 2009 |
Pathological fracture due to vertebral osteonecrosis associated with pancreatitis.
Topics: Alendronate; Bone and Bones; Bone Density Conservation Agents; Disease Progression; Fat Necrosis; Fr | 2011 |
Successful treatment of SAPHO syndrome with severe spinal disorder using entercept: a case study.
Topics: Acquired Hyperostosis Syndrome; Alendronate; Antirheumatic Agents; Bone Density Conservation Agents; | 2012 |